Lyka Labs Ltd

NSE: LYKALABS · BSE: 500259 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹74.85
Market cap: ₹267.1 Cr
Revenue (annual): ₹128.4 Cr
Net profit (annual): ₹-10.03 Cr
P/E (TTM): -30.0×Sector 47.4×
Promoter holding: 58.45%+0.29% QoQ
FII holding: 0.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Price Movement Clarification 3 Other Announcement 3 Annual General Meeting 3 Promoter Buying 2 Board Meeting Date 2 Results Update 1 Results Correction 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Apr 2026 16:45 IST BSE

Acquisition

Lyka Labs Acquisition

Lyka Labs Limited announced that its merger with Lyka Exports Limited became effective on April 8, 2026, following NCLT approval. The Appointed Date is April 1, 2022. Consequently, the company's authorized share capital automatically increased to ₹59 Crore. This consolidation aims to streamline group operations and corporate structure.

Read the filing ↗